June 2013
Volume 54, Issue 15
ARVO Annual Meeting Abstract  |   June 2013
Functional Expression Of TRPV Channels In The Retinal Endothelium
Author Affiliations & Notes
  • Jennifer McNaughten
    Queens University Belfast, Belfast, United Kingdom
  • Mary McGahon
    Queens University Belfast, Belfast, United Kingdom
  • Graham McGeown
    Queens University Belfast, Belfast, United Kingdom
  • Timothy Curtis
    Queens University Belfast, Belfast, United Kingdom
  • Footnotes
    Commercial Relationships Jennifer McNaughten, None; Mary McGahon, None; Graham McGeown, None; Timothy Curtis, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 6314. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jennifer McNaughten, Mary McGahon, Graham McGeown, Timothy Curtis; Functional Expression Of TRPV Channels In The Retinal Endothelium. Invest. Ophthalmol. Vis. Sci. 2013;54(15):6314.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: Transient receptor potential vanilloid (TRPV) channels are part of a superfamily of non-selective cation channels with a vast range of physiological functions. Our aim was to identify the functional TRPV channel subtypes expressed in the retinal endothelium.

Methods: Retinal microvascular endothelial cells (RMECs) were cultured from bovine arterioles. Fura-2-based Ca2+ microfluorimetry was used to test for the functional expression of TRPV1, V2, V3 and V4 in RMECs using a selection of agonists and antagonists.

Results: The ultrapotent TRPV1 agonist resiniferatoxin(10nM) caused a transient rise in calcium in 50% of cells tested. These responses were abolished in the presence of two different TRPV1 antagonists, capsazepine(5uM) and AMG9810(100nM). Functional expression of TRPV2 was evident from calcium peaks in response to Δ9-THC(10uM). The responses were reduced after incubation with tranilast(75uM), a TRPV2 inhibitor. Carvacrol(100uM) provided evidence for the presence of TRPV3 in RMECs causing consistant calcium responses across a number of cells. Both tranilast and carvacrol were used in the presence of the TRPA1 antagonist HC-030031(10uM). The well known TRPV4 channel was tested for using GSKA(100nM) and 4αPDD(1uM). Both elicited transient rises in calcium. The specific TRPV4 antagonist HC067047(1uM) blocks responses caused by GSKA. The aforementioned TRP channels were tested for in EGTA(1mM) buffered calcium free solution. Under these conditions none of the agonists initiated a rise in calcium suggesting the responses were mediated by calcium influx from the extracellular medium.

Conclusions: This study provides evidence for the functional expression of TRPV1-V4. This warrants further research to elucidate the physiological significance of TRP channels in endothelial cell function.

Keywords: 688 retina  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.